|
Mutation Information
|
Mutation Site
|
F23A |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
C |
Literature Information
|
PubMed PMID
|
28205569
|
|
Published Year
|
2017 |
|
Journal
|
Scientific reports |
|
Title
|
Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms. |
|
Author
|
Zhou Z,Hu T,Zhou X,Wildum S,Garcia-Alcalde F,Xu Z,Wu D,Mao Y,Tian X,Zhou Y,Shen F,Zhang Z,Tang G,Najera I,Yang G,Shen HC,Young JA,Qin N |
|
Evidence
|
Y132A or F23A mutation is known to disrupt capsid formation. Placing a bulky function group like thiazole, HAP_R01 can induce local rearrangements at F23 and Y118 of the concave and the proline-rich loop 6 (P130, A131, Y132A) of the cap.
|
|
|